Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06406244
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2024-05-05
Brief Title:
Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy
Sponsor:
West China Hospital
Organization:
West China Hospital
Study Overview
Official Title:
Efficacy of Transcutaneous Electrical Acupoint Stimulation on Chronic Pain and Survival in Patients Undergoing Hepatectomy a Prospective Randomized Controlled Trial
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a further observation and follow-up of the patients enrolled in the registration number NCT06341270 to further evaluate the efficacy of TEAS on postoperative chronic pain quality of life and survival rate in patients undergoing hepatectomy
Detailed Description:
This study is a further observation and follow-up of the patients enrolled in the registration number NCT06341270 to further evaluate the efficacy of TEAS on postoperative chronic pain and survival in patients undergoing hepatectomy Patients who meet the enrollment criteria will be randomized 11 to either the transcutaneous electrical acupoint stimulation TEASor the sham groups In the TEAS group the acupoints are bilateral neiguan PC6 Hegu L14 Yanglingquan GB34 Zusanli ST 36 and Renying ST9 acupoints Patients will receive TEAS 30 min before anesthesia until being discharged from the post-anaesthesia care unit PACU The same treatment for 30 min will be performed on the 1st 2nd and 3rd days after surgery The stimulation intensity will be adjusted in accordance with the maximal level tolerated by each patient Patients in the sham group will receive electrode attachment but without stimulation Follow-up after discharge includes chronic pain the impact of chronic pain on quality of life the relapse-free survival overall survival at 3 months and 6 months postoperatively
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None